688505.SS
Price:
$8.35
Market Cap:
$959.55M
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products. It offers genetic engineering platform drugs, including CD30-DM1 antibody-drug conjugate (ADC), which is in Phase I clinical trials for tumors; Trop2-SN38 ADC that is in Phase I clinical trials for triple negative, breast, bladder, gastric, and other tumors; Trop2-BB05 ADC that is in pre-clinical studies for lung cancer and triple negative breast cancer; and HER2 ADC that has completed pre-clinical research for metastatic breast and gastric cancers. The company also provides photodynamic technical platform drugs, such as hemoporfin...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2020-06-19
Stock Exchange
SHH
Ticker
688505.SS
According to Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is -143146575.00. This represents a change of -101.87% compared to the average of 7.67B of the last 4 quarters.
The mean historical Enterprise Value of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. over the last ten years is 22.07B. The current -143146575.00 Enterprise Value has changed -164.85% with respect to the historical average. Over the past ten years (40 quarters), 688505.SS's Enterprise Value was at its highest in in the March 2019 quarter at 34.74B. The Enterprise Value was at its lowest in in the September 2019 quarter at 0.
Average
22.07B
Median
24.72B
Minimum
6.91B
Maximum
33.83B
Discovering the peaks and valleys of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 11.50%
Maximum Annual Enterprise Value = 33.83B
Minimum Annual Increase = -53.36%
Minimum Annual Enterprise Value = 6.91B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 6.91B | -16.62% |
| 2023 | 8.29B | 11.50% |
| 2022 | 7.44B | -44.89% |
| 2021 | 13.50B | -14.19% |
| 2020 | 15.73B | -53.36% |
| 2019 | 33.73B | 0.05% |
| 2018 | 33.71B | -0.33% |
| 2017 | 33.82B | 0.19% |
| 2016 | 33.76B | -0.21% |
| 2015 | 33.83B | 0.03% |
The current Enterprise Value of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
7.55B
5-year avg
10.37B
10-year avg
22.07B
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.’s Enterprise Value is less than Changjiang Pharmaceutical Group Co., Ltd. (1.26B), less than JiangSu WuZhong Pharmaceutical Development Co., Ltd. (1.77B), less than Suzhou Iron Technology CO.,LTD. (1.69B), less than Tiansheng Pharmaceutical Group Co., Ltd. (1.64B), less than Shaanxi Kanghui Pharmaceutical Co., Ltd. (2.77B), less than Shenzhen GuoHua Network Security Technology Co., Ltd. (1.40B), less than Chengdu Huasun Technology Group Inc., Ltd. (2.79B), less than Anhui Huangshan Capsule Co., Ltd. (2.09B), less than Zhejiang Xinguang Pharmaceutical Co., Ltd. (2.17B), less than Guangdong Lifestrong Pharmacy Co., Ltd. (3.33B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 1.26B | $641.12M | |
| 1.77B | $291.46M | |
| 1.69B | $1.57B | |
| 1.64B | $1.54B | |
| 2.77B | $2.18B | |
| 1.40B | $1.44B | |
| 2.79B | $2.44B | |
| 2.09B | $2.26B | |
| 2.17B | $2.46B | |
| 3.33B | $3.40B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)?
What is the 3-year average Enterprise Value for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)?
What is the 5-year average Enterprise Value for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS)?
How does the current Enterprise Value for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (688505.SS) compare to its historical average?